Biogen, Pfizer vets launch autoimmune disease startup backed by $58M
January 18, 2018 at 07:00 AM EST
Pandion Therapeutics is developing treatments for autoimmune and inflammatory disorders that work by tweaking — rather than broadly suppressing — the immune system.
